Intel and the Michael J. Fox Foundation have combined smartwatches with analytics software to gauge the impact of Parkinson’s medications. (Intel press release here.)
25 clinical trial participants wore (originally crowdfunded) Pebble watches to track tremors, gait, sleep patterns and other indicators for four days. 300 data points per second per patient were relayed to the cloud every day. Machine learning tools analyzed the data to understand medication and treatment effectiveness and disease progression.
Intel and the foundation will launch an app for Parkinson’s patients to report their medication intake and how they are feeling. They aim to study the effects of medication on motor symptoms, based on changes detected in patient data collected from the smartwatches.